Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125497061 | 12549706 | 1 | I | 20140627 | 20160705 | 20160712 | 20160712 | EXP | US-PFIZER INC-2016334024 | PFIZER | 0.00 | F | Y | 0.00000 | 20160712 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125497061 | 12549706 | 1 | PS | CELEBREX | CELECOXIB | 1 | UNK | U | 20998 | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125497061 | 12549706 | 1 | Antiinflammatory therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125497061 | 12549706 | HO |
| 125497061 | 12549706 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125497061 | 12549706 | Asthenia | |
| 125497061 | 12549706 | Blood pressure decreased | |
| 125497061 | 12549706 | Dizziness postural | |
| 125497061 | 12549706 | Fatigue | |
| 125497061 | 12549706 | Gastrointestinal haemorrhage | |
| 125497061 | 12549706 | Gastrointestinal ulcer | |
| 125497061 | 12549706 | Internal haemorrhage | |
| 125497061 | 12549706 | Red blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125497061 | 12549706 | 1 | 20140613 | 20140627 | 0 |